Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Expenditure

Dáil Éireann Debate, Tuesday - 15 October 2019

Tuesday, 15 October 2019

Ceisteanna (452)

Michael McGrath

Ceist:

452. Deputy Michael McGrath asked the Minister for Health if the savings from the best value biologic process will be reinvested into the drugs budget for 2020; and, if so, the amount of savings that will be reinvested into the drugs budget for 2020; and if he will make a statement on the matter. [42176/19]

Amharc ar fhreagra

Freagraí scríofa

Funding is provided to the HSE for health services in accordance with the Letter of Determination which sets out the approved level of overall HSE expenditure for the year in question. It is the responsibility of the HSE to manage the entire budget and prepare and implement the National Service Plan which must, under legislation, set out the type and volume of health and personal social services, to be provided during the year in question within the funding allocated.

It is for the HSE to determine what healthcare services, products, and interventions would best maximise health gain for patients and the public within the resources available to them, including savings that would accrue from implementing new initiatives.

Barr
Roinn